Why the Best Returns Now Require Both Patience and Selective Madness

The uncomfortable truth about markets: cheap things can stay cheap, and expensive things can get even more expensive

What if the hardest investment decision today is not choosing between stocks and bonds, but deciding whether you can tolerate being early, uncomfortable, and occasionally mocked for years?

That is the strange overlap between two realities that seem unrelated at first. On one side, equities are historically expensive relative to bonds, with valuations stretched to levels that make traditional asset allocators uneasy. On the other side, there are investors looking at a small number of companies and saying, in effect, this one could matter so much that a decade is the minimum holding period.

Those two ideas are not opposites. They are the same message arriving through different doors: in an expensive market, the easy money is gone, but the biggest money still belongs to those willing to think in long arcs, concentrated bets, and nonlinear outcomes.

The tension is not just financial. It is psychological. When broad markets look rich, people feel pressure to become cautious, diversified, and defensive. But the best opportunities in that environment often do not look safe at all. They look like obsession, asymmetry, and conviction in a company that is still small compared with what it could become.

The modern investor’s problem is not a shortage of information. It is a shortage of patience calibrated to reality.

---

Expensive markets change the meaning of “good investing”

When stocks are expensive relative to bonds, the old playbook gets less effective. You cannot simply buy broad exposure, assume valuation expansion will rescue you, and expect generous returns from multiple compression and mean reversion. If bond yields rise, both sides of the portfolio can feel the pressure at once. That makes the environment feel hostile, almost unfair.

But expensive markets do something subtle: they force a distinction between owning the market and owning an exceptional business.

Those are not the same. In a richly priced market, the average company has less room to reward you. But a rare company, if it compounds through technology, execution, and scale, can still generate extraordinary returns. The trick is that the market no longer pays you for average competence. It pays you for durable superiority.

Think of it like real estate in a crowded city. If every apartment is expensive, buying any apartment is not enough. You need the one with the rare combination of location, flexibility, and long term demand. In markets, that rare apartment is a business with a deep moat, huge runway, and an execution engine that is still in the early innings.

This is why a high valuation environment does not eliminate opportunity. It changes the unit of analysis. Investors stop making money from broad bargains and start making money from precision.

In expensive markets, the question is no longer, “What is cheap?” It becomes, “What is rare enough to justify time?”

That is a much harder question. And it is also a much better one.

---

Conviction is not optimism, it is a model of time

The call to hold a stock for a decade can sound like hype, but underneath the bravado is a serious idea: some companies do not express their value on a quarterly schedule. Their true business model is not linear. It is iterative, compounding, and often invisible until the inflection arrives.

That is especially true in categories where the product itself is still maturing. Advanced machines, frontier manufacturing, infrastructure, space systems, AI tools, robotics, energy, biotech, and software platforms often look expensive in the present because the market is paying for a future that has not fully arrived. The investment thesis is not “this is cheap today.” It is “this could become important in ways the current financial statements cannot yet capture.”

This is where many investors confuse conviction with certainty. Conviction is not claiming you know the future. It is knowing which variables matter, which milestones matter, and which volatility can be ignored because it does not alter the long term thesis.

A decade-long holding period is not a slogan. It is a recognition that breakthrough companies tend to progress in phases:

1. Prototype stage: the technology or product is interesting but fragile.
2. Product market fit stage: demand becomes repeatable.
3. Scaling stage: the company learns to manufacture, distribute, or deploy at growing volume.
4. Narrative shift stage: the market stops thinking of the firm as a niche player and starts treating it as a category leader.
5. Compounding stage: the business becomes self reinforcing, and valuation can rise on top of earnings growth.

Most people arrive only for stage 4 and 5, after the hardest uncertainty is gone. The biggest returns often belong to those who survive stages 1 through 3.

The reason this matters now is that an expensive market leaves fewer obvious bargains. So capital migrates toward businesses where the payoff is not in the discount rate, but in the distance between the present and the possible future.

That is not gambling. It is a different theory of value.

---

The founder advantage: when the person matters as much as the product

One detail that changes the whole picture is when the company’s founder is also the chief engineer. That combination matters because it collapses the distance between vision and execution.

In many companies, the person selling the dream is not the person shaping the machine. Strategy gets translated through layers of management. Technical reality gets softened by corporate language. Momentum can become disconnected from craft.

But when the founder is deeply embedded in the engineering core, the company often gets a rare advantage: speed with coherence. Decisions are not just made quickly. They are made by someone who understands the system at the lowest level and can steer it without losing the original intent.

This matters in frontier businesses because technical compounding is not abstract. It is cumulative. Better systems produce better systems. Small design choices today can unlock years of efficiency later. A founder engineer is often better positioned to see those second and third order effects than a manager operating from a spreadsheet.

The market often underprices this because it likes simple financial templates. But complex companies are not built like consumer staples. They are built more like orchestras. The difference between a company led by a mission aligned engineer and one led by generic management can be the difference between genuine compounding and polished stagnation.

Still, founder advantage is not magic. It only matters if the founder has three things:

• Technical depth to understand what is actually hard.
• Taste to distinguish meaningful progress from theatrical progress.
• Endurance to keep building through years when outsiders lose interest.

Without those qualities, founder control can become a liability. With them, it can become a force multiplier.

---

The real edge in today’s market is asymmetry, not comfort

The connection between expensive markets and decade long conviction leads to a useful framework: in an expensive environment, your edge comes from asymmetry.

Asymmetry means your downside is understood and your upside is disproportionate. It means you are not asking, “How do I avoid volatility?” because volatility is the toll you pay for nonlinearity. You are asking, “How do I structure my capital and my expectations so that one or two exceptional outcomes matter more than many ordinary disappointments?”

This is why investors get trapped by the idea of “waiting for a better entry.” Sometimes that patience is wise. But sometimes it is just disguised inability to handle discomfort. In markets where greatness is scarce, the perfect entry may never arrive. A small position today in a future category leader can beat a large position in a mediocre business bought cheaply.

That does not mean ignoring valuation. It means understanding valuation as the price of optionality. When the future is uncertain, the question is not whether something looks cheap on a trailing basis. The question is whether the company can create enough scale, strategic relevance, or technological leverage to overwhelm today’s price.

Imagine two roads:

• Road A is smooth, predictable, and modest. You know where it goes, and it gets you there with limited drama.
• Road B is rough, uncertain, and occasionally absurd. But if it works, it takes you somewhere far bigger than Road A ever could.

Most investors want Road B returns with Road A emotions. That combination does not exist.

The market regime we are in seems to reward those who accept that truth. If bond yields are higher and broad equity valuations are stretched, then the easy middle ground shrinks. Either you stay defensive and accept lower expected returns, or you accept the burden of selective conviction.

---

A practical framework: the three tests of long duration investing

How do you avoid confusing hope with conviction? Use three tests.

1. The Time Test

Ask whether the company’s real value creation is likely to unfold over years, not months. If the answer is yes, you must be willing to hold through periods when the market does not understand the story.

A business that compounds over a decade cannot be judged only by next quarter’s sentiment. It must be evaluated by whether it is building capabilities that become more valuable over time.

2. The Scarcity Test

Ask whether the company does something genuinely hard, rare, or strategically important. If anyone can imitate it quickly, the long term upside will be competed away.

Scarcity can come from engineering talent, manufacturing know how, regulatory complexity, customer trust, network effects, or the sheer difficulty of execution. The more unique the capability, the more likely the business can justify patience.

3. The Founder or Culture Test

Ask whether the company has the internal coherence to survive the long journey. A great idea with weak execution often dies in the middle. A strong founder, engineer, or culture can keep the machine aligned long enough for the thesis to mature.

This is where the emotional aspect of investing becomes practical. You are not just buying a product. You are buying an organization’s ability to stay focused when the market gets impatient.

The best long term investments are not merely businesses. They are systems that can keep learning faster than the world can disrupt them.

If a company passes all three tests, the case for patience becomes rational, not romantic.

---

Key Takeaways

• In expensive markets, broad cheapness matters less than durable superiority. The best opportunities come from businesses that can compound for a long time, not from the average stock.
• Conviction should be a time horizon, not a personality trait. If a company’s value will take years to emerge, the real skill is surviving the waiting period without abandoning the thesis.
• Founder-led engineering can be a meaningful edge. When vision and technical execution live in the same person or tightly aligned culture, long term compounding becomes more plausible.
• Seek asymmetry, not comfort. In a market where both stocks and bonds can feel expensive or pressured, your edge may come from owning a few exceptional outcomes rather than trying to smooth everything out.
• Use the three tests: Time, Scarcity, and Culture. If a business fails one of them, treat your conviction with caution. If it passes all three, patience may be your highest alpha.

---

The new investor mindset: less forecasting, more faith in compounding

The deepest lesson here is not about one stock, one bond market, or one valuation metric. It is about how value changes when the whole system becomes expensive.

In a cheap world, you can make money by being careful and average. In an expensive world, careful and average is often just another way to underperform. The market starts rewarding those who can identify rare businesses, tolerate long periods of uncertainty, and understand that greatness tends to arrive slowly, then all at once.

That is why the most interesting investments today may not feel comfortable. They may require a decade. They may be led by a founder who seems obsessed. They may look too ambitious relative to conventional valuation models. But if the underlying machine is real, if the engineering is credible, and if the product can keep scaling, then the market’s short term discomfort can become the investor’s long term advantage.

The real shift is this: in a world of expensive assets, patience is no longer passive. It becomes active selection.

And that changes everything. Not because the future is easy to predict, but because the best outcomes now belong to those willing to wait for them to become undeniable.